The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Insmed Inc  (INSM) Trade Now »     Rate INSM  -  Discuss INSM  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
0.0%
Rate INSM:



INSM Analysis & Videos »


INSM: Bull or Bear?

BioMedReports FDA Calendar: Hot Summer Trades Graphic_rating_buy INSM
Mikerun
73%
 -49.77%
in 9 days
(closed on 06/25/09)
Below is a sample of entries from the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The companies outlined below have expected FDA new drug product decisions or clinical trial results expected over the next three months of summer. The list also includes some <font> Extreme Trades </font> of companies with market caps below $250 million that have pending clinical trial results or FDA decisions that could have a major stock price impact.
 
<> <font> http://biomedreports.com/articles/most-popular/1355-biomedrep... </font>...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/16/09 1 comment


FDA, Clinical Trial Calendar Updates: Insmed, Jazz Pharma Await Key Results Graphic_rating_buy INSM
Mikerun
73%
 +67.97%
in 34 days
(closed on 06/16/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
By  Mike Havrilla   (+1.04%  risk: conservative)  05/13/09 Comment





People Bullish on INSM

roby1050
Analyst
N/A
4 mos ago

450vampyr_avatar-med
supratrader
Principal
N/A
5 mos ago

Foto
Marian Filo
Principal
62%
5 mos ago

tms2x2
Analyst
N/A
about 1 year ago

timsah
Analyst
N/A
about 1 year ago


People Bearish on INSM

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
MO Altria Group Inc
MCD McDonald's Corp.
BAC Bank of America Corp
AAPL Apple Computer Inc
V Visa Inc
GS Goldman Sachs Group Inc The

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on INSM


Discussion Wall + Add  
amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About Insmed Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch